BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26885364)

  • 1. Correlation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu, Nepal.
    Neupane S; Pant ND; Khatiwada S; Chaudhary R; Banjara MR
    Antimicrob Resist Infect Control; 2016; 5():5. PubMed ID: 26885364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended spectrum β-lactamase producing uropathogenic Escherichia coli and the correlation of biofilm with antibiotics resistance in Nepal.
    Shrestha R; Khanal S; Poudel P; Khadayat K; Ghaju S; Bhandari A; Lekhak S; Pant ND; Sharma M; Marasini BP
    Ann Clin Microbiol Antimicrob; 2019 Dec; 18(1):42. PubMed ID: 31847837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the effectiveness of three different cephalosporin/clavulanate combinations for the phenotypic confirmation of extended-spectrum beta-lactamase producing bacteria isolated from urine samples at National Public Health Laboratory, Kathmandu, Nepal.
    Bhandari R; Pant ND; Poudel A; Sharma M
    BMC Res Notes; 2016 Aug; 9():390. PubMed ID: 27488224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biofilm and metallo beta-lactamase production among the strains of Pseudomonas aeruginosa and Acinetobacter spp. at a Tertiary Care Hospital in Kathmandu, Nepal.
    Baniya B; Pant ND; Neupane S; Khatiwada S; Yadav UN; Bhandari N; Khadka R; Bhatta S; Chaudhary R
    Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):70. PubMed ID: 29096652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid Profiling and Occurrence of β-Lactamase Enzymes in Multidrug-Resistant Uropathogenic
    Thapa Shrestha U; Shrestha S; Adhikari N; Rijal KR; Shrestha B; Adhikari B; Banjara MR; Ghimire P
    Infect Drug Resist; 2020; 13():1905-1917. PubMed ID: 32606839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
    Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
    Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Laboratory Profile of Urinary Tract Infections Associated with Extended Spectrum β-Lactamase Producing Escherichia coli and Klebsiella pneumoniae.
    Al Yousef SA; Younis S; Farrag E; Moussa HSh; Bayoumi FS; Ali AM
    Ann Clin Lab Sci; 2016 Jul; 46(4):393-400. PubMed ID: 27466299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rates of multidrug resistance among uropathogenic
    Parajuli NP; Maharjan P; Parajuli H; Joshi G; Paudel D; Sayami S; Khanal PR
    Antimicrob Resist Infect Control; 2017; 6():9. PubMed ID: 28096977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between biofilm formation and antimicrobial susceptibility pattern toward extended spectrum β-lactamase (ESBL)- and non-ESBL-producing uropathogenic bacteria.
    Hasan ME; Shahriar A; Shams F; Nath AK; Emran TB
    J Basic Clin Physiol Pharmacol; 2020 Jan; 32(2):. PubMed ID: 31927517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher Prevalence of Extended Spectrum β-Lactamase Producing Uropathogenic Escherichia coli Among Patients with Diabetes from a Tertiary Care Hospital of Kathmandu, Nepal.
    Nayaju T; Upreti MK; Ghimire A; Shrestha B; Maharjan B; Joshi RD; Lekhak B; Thapa Shrestha U
    Am J Trop Med Hyg; 2021 Aug; 105(5):1347-1355. PubMed ID: 34424860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of extended spectrum beta-lactamase producing uropathogens and their antibiotic resistance profile in patients visiting a tertiary care hospital in central India: Implications on empiric therapy.
    Bajpai T; Pandey M; Varma M; Bhatambare GS
    Indian J Pathol Microbiol; 2014; 57(3):407-12. PubMed ID: 25118732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypes of Escherichia coli isolated from urine: Differences between extended-spectrum β-lactamase producers and sensitive strains.
    Šišková P; Černohorská L; Mahelová M; Turková K; Woznicová V
    J Microbiol Immunol Infect; 2015 Jun; 48(3):329-34. PubMed ID: 24865414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal groups of extended-spectrum β-lactamase and biofilm producing uropathogenic
    Qasemi A; Rahimi F; Katouli M
    Pathog Glob Health; 2022 Dec; 116(8):485-497. PubMed ID: 34904540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AmpC and extended spectrum beta-lactamases production among urinary isolates from a tertiary care hospital in Lalitpur, Nepal.
    Rai S; Pant ND; Bhandari R; Giri A; Parajuli R; Aryal M; Amatya J; Sharma VK
    BMC Res Notes; 2017 Sep; 10(1):467. PubMed ID: 28882177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-Resistance and Extended Spectrum Beta-Lactamase Production in Uropathogenic E. Coli which were Isolated from Hospitalized Patients in Kolkata, India.
    Mukherjee M; Basu S; Mukherjee SK; Majumder M
    J Clin Diagn Res; 2013 Mar; 7(3):449-53. PubMed ID: 23634394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current antibiotic resistance profile of uropathogenic Escherichia coli strains and therapeutic consequences].
    El Bouamri MC; Arsalane L; Kamouni Y; Yahyaoui H; Bennouar N; Berraha M; Zouhair S
    Prog Urol; 2014 Dec; 24(16):1058-62. PubMed ID: 25310915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro biofilm formation by uropathogenic Escherichia coli and their antimicrobial susceptibility pattern.
    Ponnusamy P; Natarajan V; Sevanan M
    Asian Pac J Trop Med; 2012 Mar; 5(3):210-3. PubMed ID: 22305786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of antibiotic treatments for urinary tract infections in the elderly, especially regarding the effect on extended spectrum β-lactamase producing (ESBL-) Escherichia coli: A comparison between meropenem and alternatives].
    Yamamoto A; Yamasaki K
    Nihon Ronen Igakkai Zasshi; 2015; 52(2):153-61. PubMed ID: 25994987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.